268 related articles for article (PubMed ID: 32966294)
21. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
22. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
[TBL] [Abstract][Full Text] [Related]
23. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
[TBL] [Abstract][Full Text] [Related]
24. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma.
Schrenk P; Rieger R; Shamiyeh A; Wayand W
Cancer; 2000 Feb; 88(3):608-14. PubMed ID: 10649254
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study.
Chéreau E; Uzan C; Boutmy-Deslandes E; Zohar S; Bézu C; Mazouni C; Garbay JR; Daraï E; Rouzier R
PLoS One; 2016; 11(6):e0156096. PubMed ID: 27280398
[TBL] [Abstract][Full Text] [Related]
26. Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active.
Nielsen HM; Friis RB; Linnet S; Offersen BV
Acta Oncol; 2017 May; 56(5):713-718. PubMed ID: 28105873
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - Randomised controlled trial.
Abdelhamid MI; Bari AA; Farid MI; Nour H
Int J Surg; 2020 Mar; 75():174-178. PubMed ID: 32059974
[TBL] [Abstract][Full Text] [Related]
28. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
29. Five-Year Cumulative Incidence of Axillary Web Syndrome and Comparison in Upper Extremity Movement, Function, Pain, and Lymphedema in Survivors of Breast Cancer With and Without Axillary Web Syndrome.
Koehler L; Day A; Hunter D; Blaes A; Haddad T; Shanley R
Arch Phys Med Rehabil; 2022 Sep; 103(9):1798-1806. PubMed ID: 35398047
[TBL] [Abstract][Full Text] [Related]
30. Manual lymphatic drainage versus exercise in the early postoperative period for breast cancer.
de Oliveira MM; de Rezende LF; do Amaral MT; Pinto e Silva MP; Morais SS; Gurgel MS
Physiother Theory Pract; 2014 Aug; 30(6):384-9. PubMed ID: 24410411
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of a self-administered, home-based exercise rehabilitation program for women following a modified radical mastectomy and axillary node dissection: a preliminary study.
Kilgour RD; Jones DH; Keyserlingk JR
Breast Cancer Res Treat; 2008 May; 109(2):285-95. PubMed ID: 17624606
[TBL] [Abstract][Full Text] [Related]
32. Early and late morbidity associated with axillary levels I-III dissection in breast cancer.
Ernst MF; Voogd AC; Balder W; Klinkenbijl JH; Roukema JA
J Surg Oncol; 2002 Mar; 79(3):151-5; discussion 156. PubMed ID: 11870664
[TBL] [Abstract][Full Text] [Related]
33. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
Mansel RE; Fallowfield L; Kissin M; Goyal A; Newcombe RG; Dixon JM; Yiangou C; Horgan K; Bundred N; Monypenny I; England D; Sibbering M; Abdullah TI; Barr L; Chetty U; Sinnett DH; Fleissig A; Clarke D; Ell PJ
J Natl Cancer Inst; 2006 May; 98(9):599-609. PubMed ID: 16670385
[TBL] [Abstract][Full Text] [Related]
34. A descriptive study on prevalence of arm/shoulder problems and its impact on quality of life in breast cancer survivors.
Jariwala P; Kaur N
Indian J Cancer; 2021; 58(2):201-206. PubMed ID: 33402566
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of an antiadhesive agent for the prevention of intra-abdominal adhesions after radical gastrectomy: A prospective randomized, multicenter trial.
Kim SG; Song KY; Lee HH; Kim EY; Lee JH; Jeon HM; Jeon KH; Jin HM; Kim DJ; Kim W; Yoo HM; Kim JG; Park CH
Medicine (Baltimore); 2019 May; 98(19):e15141. PubMed ID: 31083151
[TBL] [Abstract][Full Text] [Related]
36. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for seroma formation after axillary lymph node dissection with special focus on the impact of early shoulder exercise.
Borg G; Dihge L; Johansson K
Acta Oncol; 2023 May; 62(5):444-450. PubMed ID: 37129993
[TBL] [Abstract][Full Text] [Related]
38. Physical and psychological morbidity after axillary lymph node dissection for breast cancer.
Hack TF; Cohen L; Katz J; Robson LS; Goss P
J Clin Oncol; 1999 Jan; 17(1):143-9. PubMed ID: 10458227
[TBL] [Abstract][Full Text] [Related]
39. Complete versus selective axillary lymph node dissection in treatment of early breast carcinoma.
Sharaf MF
J Egypt Soc Parasitol; 2012 Apr; 42(1):207-16. PubMed ID: 22662610
[TBL] [Abstract][Full Text] [Related]
40. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
